Liver Diseases Global Clinical Trials Review, H2, 2017 - Product Image

Liver Diseases Global Clinical Trials Review, H2, 2017

  • ID: 4453128
  • Clinical Trials
  • Region: Global
  • 1009 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
Liver Diseases Global Clinical Trials Review, H2, 2017

Summary

The clinical trial report, “Liver Diseases Global Clinical Trials Review, H2, 2017" provides an overview of Liver Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Liver Diseases to Gastrointestinal Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Liver Diseases to Gastrointestinal Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Liver Diseases Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Liver Diseases
Nov 13, 2017: AdAlta to present at Anti-Fibrotic Drug Development Summit in Boston
Oct 23, 2017: Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting 2017
Oct 10, 2017: Arrowhead Pharmaceuticals to Present Preclinical Data on ARO-AAT at The Liver Meeting
Oct 10, 2017: Dova Pharmaceuticals to Present Phase 3 Avatrombopag Data at the 2017 Liver Meeting of the American Association for the Study of Liver Diseases
Oct 03, 2017: Final Results of Albireos Phase 2 Study of A4250 in Children with Cholestatic Liver Disease to be Presented at The Liver Meeting 2017
Sep 25, 2017: Alnylam Continues Leadership in RNAi Technologies and Delivery with New Pre-Clinical Data Presented on Enhanced Stabilization Chemistry Plus GalNAc-siRNA Conjugate Platform at 13th Annual Meeting of the Oligonucleotide Therapeutics Society
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About
Contact
Source

List of Tables
Liver Diseases Therapeutics, Global, Clinical Trials by Region, 2017*
Liver Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Liver Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
Liver Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Liver Diseases Therapeutics Clinical Trials, North America, Top Countries, 2017*
Liver Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*
Liver Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*
Proportion of Liver Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2017*
Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Liver Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2017*
Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Liver Diseases Therapeutics, Global, Clinical Trials by Phase, 2017*
Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Liver Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Liver Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

List of Figures
Liver Diseases Therapeutics, Global, Clinical Trials by Region (%), 2017*
Liver Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Liver Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*
Liver Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
Liver Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
Liver Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*
Liver Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017*
Proportion of Liver Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2017*
Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Liver Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2017*
Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Liver Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2017*
Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
Liver Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Liver Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Liver Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
Methodology 1
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novartis AG
  • Pfizer Inc
  • Gilead Sciences Inc
  • Merck & Co Inc
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche Ltd
  • Conatus Pharmaceuticals Inc
  • AstraZeneca Plc
  • C. H. Boehringer Sohn AG & Co KG
  • Bristol-Myers Squibb Co
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll